Interv Akut Kardiol. 2011;10(3):109-112

Drug-coated balloon

Ivo Varvařovský
Kardio-Troll, pracoviště invazivní kardiologie, Krajská nemocnice, Pardubice

Drug-coated balloon (drug-eluting balloon, DEB) emerged as effective treatment of in-stent restenosis with great potential for the

extension of treatment indications for other areas of coronary interventions. Drug-eluting balloon may become a good alternative for

drug-eluting stents with comparable effectiveness and better safety profile. However, great expectations are attenuated with the first

results of the clinical trial PEPCAD III.

Keywords: coronary angioplasty, drug-coated balloon, restenosis

Published: June 10, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Varvařovský I. Drug-coated balloon. Interv Akut Kardiol. 2011;10(3):109-112.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Axel DI, Kuvert W, Goggelmann C. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 1997; 96: 636-645. Go to original source... Go to PubMed...
    2. Moses JW, Kipshidze N, Leon MB. Perspectives of drugeluting stents: the next revolution. Am J Cardiovasc Drugs 2002; 2: 163-172. Go to original source... Go to PubMed...
    3. Scheller B, Speck U, Schmitt A. Acute cardiac tolerance of current contrast media and the new taxane protaxel using iopromide as carrier during porcine coronary angioplasty and stenting. Invest Radiol 2002; 37: 29-34. Go to original source... Go to PubMed...
    4. Scheller B, Speck U, Romeike B. Contrast media as carriers for local drug delivery. Eur Heart J 2003; 24: 1462-1467. Go to original source... Go to PubMed...
    5. Scheller B, Speck U, Abramjuk C. Paclitaxel balloon coating - a novel method for prevention and therapy of restenosis. Circulation 2004; 110: 810-814. Go to original source... Go to PubMed...
    6. Scheller B, Hehrlein C, Bocksch W. Treatment of in-stent restenosis with a paclitaxel-coated balloon catheter. New Engl J Med 2006; 355: 2113-2124. Go to original source... Go to PubMed...
    7. Cremers B, Biedermann M, Mahnkopf D. Comparison of paclitaxel coated PACCOCATH(R) and DIOR(R) drug eluting balloon catheters in the porcine coronary restenosis model. Clin Res Cardiol 2009; 98: 325-330. Go to original source... Go to PubMed...
    8. De Labriolle A, Pakala R, Bonello L. Paclitaxel-eluting balloon: from bench to bed. Catheter Cardiovasc Interv 2009; 73: 643-652. Go to original source... Go to PubMed...
    9. Balakrishnan B, Dooley JF, Kopia G. Intravascular drug release kinetics dictate arterial drug deposition, retention, and distribution. J Control Release 2007; 123: 100-108. Go to original source... Go to PubMed...
    10. Scheller B, Speck U, Abramjuk C. Paclitaxel balloon coating - a novel method for prevention and therapy of restenosis. Circulation 2004; 110: 810-814. Go to original source... Go to PubMed...
    11. Scheller B, Speck U, Abramjuk C. Restenosis inhibition by non-stent-based local drug delivery: comparison of efficacy to a drug eluting stent in the porcine coronary overstretch model. Radiology 2006; 240: 411-418. Go to original source... Go to PubMed...
    12. Cremers B, Speck U, Kaufels N. Drug-eluting balloon: very short-term exposure and overlapping. Thromb Haemost 2009; 101: 201-206. Go to original source... Go to PubMed...
    13. Schnorr B, Kelsch B, Cremers B. Paclitaxel-coated balloons - survey of preclinical data. Minerva Cardioangiol 2010; 58: 567-582. Go to PubMed...
    14. Scheller B, Hehrlein C, Bocksh W. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006; 355: 2113-2124. Go to original source... Go to PubMed...
    15. Scheller B, Hehrlein C, Bocksh W. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxelcoated balloon catheter. Clin Res Cardiol 2008; 97: 773-781. Go to original source... Go to PubMed...
    16. Rosenkranz S, Maier LS, Maack C. Hotline update of clinical trials and registries presented at the German Cardiac Society Meeting 2007. Clin Res Cardiol 2007; 96: 457-468. Go to original source... Go to PubMed...
    17. Maier LS, Maack C, Ritter O. Hotline update of clinical trials and registries presented at the German Cardiac Society Meeting 2008. Clin Res Cardiol 2008; 97: 356-363. Go to original source... Go to PubMed...
    18. Poss J, Jacobshagen C, Ukena C. Hotlines and clinical trial updates presented at the German Cardiac Society Meeting 2010. Clin Res Cardiol 2010; 99: 411-417. Go to original source... Go to PubMed...
    19. Banning AP, Lim CS. Drug eluting balloons: what is their place on the interventionalist´s shelf? Heart 2010; 96: 1257-1258. Go to original source... Go to PubMed...
    20. Cortese B, Micheli A, Picchi A. Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels: a prospective randomised clinical trial. The PICCOLETO study. Heart 2010; 96: 1291-1296. Go to original source... Go to PubMed...
    21. Cremers B, Clever Y, Schaffner S. Treatment of coronary in-stent restenosis with a novel paclitaxel coated balloon. Minerva Cardioangiol 2010; 58: 583-588. Go to PubMed...
    22. Herdeg C, Gohring-Frischholz K, Haase KK. Catheterbased delivery of fluid paclitaxel for prevention of restenosis in native coronary lesions after stent implantation. Circ Cardiovasc Interv 2009; 2: 294-301. Go to original source... Go to PubMed...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.